InvestorsHub Logo
Followers 19
Posts 6059
Boards Moderated 3
Alias Born 05/23/2019

Re: None

Wednesday, 10/23/2019 11:44:10 AM

Wednesday, October 23, 2019 11:44:10 AM

Post# of 83009
Wolf Obsevation and Logical opinion. Have Mercy Wolf ahooooooo

If : Mona is prohibited from being an officer or Director for a public company for 5 years

Then: Mona is not vesting for 5 years.

Therefore: Mona could become an officer and/ or Director of CV Sciences in five years and will not Vest within those five years.

If Mona vests his options within the five years, as long as his son is an officer and Director, he will most likely pay the income taxes as well.


Back in June 2017, the Securities and Exchange Commission filed an enforcement action against the company and then-CEO Michael Mona. This action concerned financial reporting irregularities related to an acquisition back in 2013. A year later, CV Sciences announced that there had been a settlement in the action. Without admitting wrongdoing, the company paid $150,000, and Mr. Mona agreed to an order that prohibits him from serving as an officer or director of a public company for five years. Mr. Mona also paid a $50,000 penalty.


https://www.marketwatch.com/press-release/cv-sciences-inc-otcmktscvsi-files-an-8-k-other-events-2019-04-02

On March 31, 2019, CV Sciences, Inc. (the “Company”) and Michael Mona, Jr. (“Mona”), the former President and Chief Executive Officer of CV Sciences, Inc. (the “Company”), entered into a Settlement Agreement (the “Settlement Agreement”), to which the Company agreed that Mona’s resignation from the Company on January 22, 2019 was for Good Reason (as defined in Mona’s Employment Agreement) and agreed to extend the deadline for Mona’s exercise of his stock options for a period of five (5) years. In exchange, Mona agreed that notwithstanding the terms of his Employment Agreement providing for acceleration of vesting of all stock options and Restricted Stock Units upon a Good Reason resignation, certain of his unvested stock options would not immediately vest, but rather continue to vest if, and only if, certain Company milestones are achieved related to the Company’s drug development efforts. These stock options were issued in July 2016 (6,000,000 options) and March 2017 (5,000,000 options). The Company and Mona also agreed to mutually release all claims arising out of and related to Mona’s resignation and separation from the Company.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News